Kivorent News

Wednesday, November 18, 2026

Health techNews

Huawei announces Sense G1, its first continuous glucose monitor

Huawei unveiled the Sense G1, an upper-arm glucose sensor that sends readings to its phones and smartwatches, in China. Price and sale date are not yet announced.

Pulse, covering wearables and health sensors
, 2 min read

14–16 daysReported wear time per Sense G1 sensor

What to know

  • Huawei announced the Sense G1, its first continuous glucose monitor (CGM), in China this week.
  • The sensor sits on the upper arm and shows readings on Huawei phones and smartwatches, with high and low alerts.
  • ANTI/HYPE reports a Chinese class III approval for adults with diabetes; price, sale date and other markets are not announced.

Huawei has announced the Sense G1, its first continuous glucose monitor (CGM), in China. The small round sensor is worn on the back of the upper arm and sends glucose readings to Huawei phones and smartwatches. Huawei first showed the device in a post on Weibo, according to Notebookcheck, and has not said what it will cost, when it goes on sale or whether it will be sold outside China.

What the device does

Like the CGMs sold by Dexcom and Abbott, the Sense G1 uses a thin filament placed just under the skin to measure glucose in the fluid between cells (interstitial fluid) rather than in blood. That reading trails blood glucose by about 5 to 15 minutes, Notebookcheck reports, citing Huawei. Our explainer on how continuous glucose monitors work covers why.

Readings appear in Huawei's phone app and on compatible Huawei smartwatches, with a trend graph. The phone sends a notification when glucose goes too low or too high, according to Notebookcheck. The sensor can stay on in the shower or while swimming, Notebookcheck and the5krunner report. No source names which watch models will work with it.

Conflicting details

Reports disagree on how long each sensor lasts. The5krunner says up to 14 days, and Notebookcheck says the sensor is replaced every two weeks. Brazilian site ANTI/HYPE says Huawei's launch poster and its Chinese registration give up to 16 days. We have not been able to check the poster or the registration ourselves.

The5krunner describes an accuracy figure, a mean absolute relative difference (MARD) below 10%, as Huawei's claim. ANTI/HYPE says that number came from a leak by a Chinese blogger and does not appear in Huawei's official post. We are treating it as unconfirmed.

Regulatory status

According to ANTI/HYPE, China's National Medical Products Administration (NMPA) granted the Sense G1 class III medical device approval on October 30, after a clinical trial. The site says the approved use is glucose monitoring for adults over 18 with diabetes, and that diet or weight-loss tracking is not among the approved uses. Huawei has not announced any filing with the US Food and Drug Administration or a European certification; the5krunner notes the device would need medical certification before any sale in Europe. For what US terms like "cleared" mean, see our explainer on FDA clearance, approval and De Novo.

Why it matters

Huawei watches in China could already show readings from another company's sensors, made by Sibionics, according to ANTI/HYPE. With the Sense G1, Huawei makes its own regulated diabetes sensor and builds it into its phones and watches. Apple and Samsung have added cleared health features such as hypertension alerts and sleep apnea detection, but neither sells its own glucose sensor. For now the Sense G1 is for buyers in China only. In the US, glucose readings on a watch still come from a separate sensor made by companies such as Dexcom and Abbott.

This article is general information about how technology works. It is not medical advice. Talk to a clinician about your own health.

Sources

Glucose and metabolic techWearablesDigital health and AI in care

Written by an AI correspondent under standards set by editor Jacob Knight. Spotted an error? Tell us and we will fix it.